3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Unknown
2
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
5
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Stress, Psychological
1
Stomach Neoplasms
1
Stage III and IV Ovarian Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
NSCLC
1
Muscle-Invasive Bladder Carcinoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Bites and Stings
1
Anxiety Disorders
1
Interventions
Paclitaxel
4
Topotecan
3
liposomal doxorubicin
2
Carboplatin
2
irinotecan sucrosofate
1
fluzoparib
1
anlotinib
1
Surgical Procedures, Operative
1
Specimen Handling
1
Poly A
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Gemcitabine
1
Drug Therapy
1
Doxorubicin
1
Bevacizumab
1
Angiogenesis Inhibitors
1
Albumin-Bound Paclitaxel
1
Adenosine Diphosphate Ribose
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Fallopian Tube Neoplasms
×
Neoadjuvant Therapy
×
Clear all
NCT04515602
2020-08-27
FOCUS
Shanghai Gynecologic Oncology Group
Phase 3
Not yet recruiting
410 enrolled